This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Chemplast Sep 2026 consolidated quarter: revenue up 28%, after-tax loss Rs 5.45 crore vs Sep 2025
CHEMPLASTS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.7 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
In the unaudited consolidated quarter ended 30 September 2026, revenue rose 28.1% to Rs 1,323.21 crore from Rs 1,033.20 crore a year earlier; loss after tax was Rs 5.45 crore versus Rs 51.04 crore. EBITDA margin rose to 8.4% from 4.6%. Standalone showed a Rs 11.48 crore quarter loss after tax and a Rs 100 crore half-year loan to its subsidiary. Half-year consolidated loss after tax was Rs 181.03 crore; operating cash flow was Rs 458.31 crore.
Revenue growth and a narrower loss help, but the company remains loss-making. Consolidated borrowings are 1.11 times equity, a risk for shareholders.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹1,323 Cr | ₹1,033 Cr | +28.1% |
| Operating profit | −₹12.15 Cr | −₹69.18 Cr | loss narrowed |
| Profit after tax | −₹5.45 Cr | −₹51.04 Cr | loss narrowed |
| EBITDA margin | 8.4% | 4.2% | +4.2 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.